Krishna Instit Of Medical Scienc Share Price
Sector: Healthcare Facilities
660.00 +7.10 (1.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
652
Today’s High
670
52 Week Low
350.02
52 Week High
707.50
656.30 +4.75 (0.73%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
651.55
Today’s High
668.95
52 Week Low
350
52 Week High
708
Key Metrics
- Market Cap (In Cr) 26484.24
- Beta 0.72
- Div. Yield (%) 0
- P/B 14.26
- TTM P/E 68.73
- Peg Ratio 4.83
- Sector P/E 23.64
- Open Price 670
- Prev Close 652.9
Krishna Instit Of Medical Scienc Analysis
Price Analysis
-
1 Week-1.53%
-
3 Months6.37%
-
6 Month15.74%
-
YTD8.95%
-
1 Year63.01%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 5
- Buy
- 3
- 3
- 3
- 3
- Hold
- 1
- 1
- 1
- 1
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 9
- 9
- 9
- 9
Krishna Instit Of Medical Scienc News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 18 Mar 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 13 Mar 2025Dr Agarwal’s vs KIMS: Which healthcare firm is poised for greater growth?
5 min read . 05 Feb 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 05 Feb 2025Krishna Instit Of Medical Scienc Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 3035.1
- Selling/ General/ Admin Expenses Total
- 499.5
- Depreciation/ Amortization
- 177.2
- Other Operating Expenses Total
- 1125.8
- Total Operating Expense
- 2418.6
- Operating Income
- 616.5
- Net Income Before Taxes
- 558.1
- Net Income
- 384.5
- Diluted Normalized EPS
- 9.41
- Period
- 2025
- Total Assets
- 5736
- Total Liabilities
- 3598.2
- Total Equity
- 2137.8
- Tangible Book Valueper Share Common Eq
- 43.27
- Period
- 2025
- Cashfrom Operating Activities
- 582.2
- Cashfrom Investing Activities
- -1116.2
- Cashfrom Financing Activities
- 543.1
- Net Changein Cash
- 9.1
- Period
- 2024
- Total Revenue
- 2498.14
- Selling/ General/ Admin Expenses Total
- 676.96
- Depreciation/ Amortization
- 146.55
- Other Operating Expenses Total
- 22.42
- Total Operating Expense
- 2003.79
- Operating Income
- 494.35
- Net Income Before Taxes
- 459.64
- Net Income
- 310.15
- Diluted Normalized EPS
- 7.74
- Period
- 2024
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 36.38
- Period
- 2024
- Cashfrom Operating Activities
- 521.09
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023
- Total Revenue
- 2197.68
- Selling/ General/ Admin Expenses Total
- 564.4
- Depreciation/ Amortization
- 129.26
- Other Operating Expenses Total
- 6.04
- Total Operating Expense
- 1706.63
- Operating Income
- 491.05
- Net Income Before Taxes
- 484.91
- Net Income
- 336.32
- Diluted Normalized EPS
- 8.11
- Period
- 2023
- Total Assets
- 2941.3
- Total Liabilities
- 1271.76
- Total Equity
- 1669.54
- Tangible Book Valueper Share Common Eq
- 32.08
- Period
- 2023
- Cashfrom Operating Activities
- 563.23
- Cashfrom Investing Activities
- -615.6
- Cashfrom Financing Activities
- 88.34
- Net Changein Cash
- 35.98
- Period
- 2022
- Total Revenue
- 1650.83
- Selling/ General/ Admin Expenses Total
- 421.91
- Depreciation/ Amortization
- 72.67
- Other Operating Expenses Total
- 5.33
- Total Operating Expense
- 1203.68
- Operating Income
- 447.14
- Net Income Before Taxes
- 456.85
- Net Income
- 332.69
- Diluted Normalized EPS
- 8.43
- Period
- 2022
- Total Assets
- 1907.35
- Total Liabilities
- 520.04
- Total Equity
- 1387.31
- Tangible Book Valueper Share Common Eq
- 31.76
- Period
- 2022
- Cashfrom Operating Activities
- 324.03
- Cashfrom Investing Activities
- -411.52
- Cashfrom Financing Activities
- 61
- Net Changein Cash
- -26.49
- Period
- 2021
- Total Revenue
- 1329.94
- Selling/ General/ Admin Expenses Total
- 357.9
- Depreciation/ Amortization
- 69.54
- Other Operating Expenses Total
- 4.06
- Total Operating Expense
- 1026.8
- Operating Income
- 303.14
- Net Income Before Taxes
- 279.02
- Net Income
- 201.22
- Diluted Normalized EPS
- 5.05
- Period
- 2021
- Total Assets
- 1436.15
- Total Liabilities
- 572.42
- Total Equity
- 863.73
- Tangible Book Valueper Share Common Eq
- 18.85
- Period
- 2021
- Cashfrom Operating Activities
- 355.97
- Cashfrom Investing Activities
- -354.18
- Cashfrom Financing Activities
- 9.82
- Net Changein Cash
- 11.62
- Period
- 2020
- Total Revenue
- 1122.65
- Selling/ General/ Admin Expenses Total
- 329.18
- Depreciation/ Amortization
- 70.61
- Other Operating Expenses Total
- 3.43
- Total Operating Expense
- 946.22
- Operating Income
- 176.42
- Net Income Before Taxes
- 140.53
- Net Income
- 119.18
- Diluted Normalized EPS
- 3
- Period
- 2020
- Total Assets
- 1195.89
- Total Liabilities
- 597.77
- Total Equity
- 598.13
- Tangible Book Valueper Share Common Eq
- 12.17
- Period
- 2020
- Cashfrom Operating Activities
- 201.5
- Cashfrom Investing Activities
- -124.71
- Cashfrom Financing Activities
- -44.34
- Net Changein Cash
- 32.45
- Period
- 2019
- Total Revenue
- 918
- Selling/ General/ Admin Expenses Total
- 298.76
- Depreciation/ Amortization
- 56.46
- Other Operating Expenses Total
- 3.05
- Total Operating Expense
- 805.44
- Operating Income
- 112.56
- Net Income Before Taxes
- -15.38
- Net Income
- -47.77
- Diluted Normalized EPS
- -1.19
- Period
- 2019
- Total Assets
- 1119.71
- Total Liabilities
- 579.05
- Total Equity
- 540.66
- Tangible Book Valueper Share Common Eq
- 10.97
- Period
- 2019
- Cashfrom Operating Activities
- 133.9
- Cashfrom Investing Activities
- -109.76
- Cashfrom Financing Activities
- -27.04
- Net Changein Cash
- -2.9
- Period
- 2018
- Total Revenue
- 663.67
- Selling/ General/ Admin Expenses Total
- 200.85
- Depreciation/ Amortization
- 40.07
- Other Operating Expenses Total
- 2.21
- Total Operating Expense
- 534.69
- Operating Income
- 128.98
- Net Income Before Taxes
- -20.45
- Net Income
- -47.36
- Diluted Normalized EPS
- -8.58
- Period
- 2018
- Total Assets
- 958.01
- Total Liabilities
- 1116.45
- Total Equity
- -158.44
- Tangible Book Valueper Share Common Eq
- -25.47
- Period
- 2018
- Cashfrom Operating Activities
- 105.77
- Cashfrom Investing Activities
- -63.73
- Cashfrom Financing Activities
- -39.36
- Net Changein Cash
- 2.68
- Period
- 2025-03-31
- Total Revenue
- 796.9
- Selling/ General/ Admin Expenses Total
- 134.1
- Depreciation/ Amortization
- 52.6
- Other Operating Expenses Total
- 297.7
- Total Operating Expense
- 640.7
- Operating Income
- 156.2
- Net Income Before Taxes
- 134
- Net Income
- 101.8
- Diluted Normalized EPS
- 2.33
- Period
- 2025-03-31
- Total Assets
- 5736
- Total Liabilities
- 3598.2
- Total Equity
- 2137.8
- Tangible Book Valueper Share Common Eq
- 43.27
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 582.2
- Cashfrom Investing Activities
- -1116.2
- Cashfrom Financing Activities
- 543.1
- Net Changein Cash
- 9.1
- Period
- 2024-12-31
- Total Revenue
- 772.4
- Selling/ General/ Admin Expenses Total
- 127.5
- Depreciation/ Amortization
- 44.7
- Other Operating Expenses Total
- 295.9
- Total Operating Expense
- 629.9
- Operating Income
- 142.5
- Net Income Before Taxes
- 134.6
- Net Income
- 88.7
- Diluted Normalized EPS
- 2.22
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 777.3
- Selling/ General/ Admin Expenses Total
- 119.2
- Depreciation/ Amortization
- 41
- Other Operating Expenses Total
- 284.5
- Total Operating Expense
- 600.2
- Operating Income
- 177.1
- Net Income Before Taxes
- 162.2
- Net Income
- 107.4
- Diluted Normalized EPS
- 2.68
- Period
- 2024-09-30
- Total Assets
- 4578.7
- Total Liabilities
- 2576.7
- Total Equity
- 2002
- Tangible Book Valueper Share Common Eq
- 38.91
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 246.5
- Cashfrom Investing Activities
- -469.5
- Cashfrom Financing Activities
- 239.3
- Net Changein Cash
- 16.3
- Period
- 2024-06-30
- Total Revenue
- 688.4
- Selling/ General/ Admin Expenses Total
- 118.6
- Depreciation/ Amortization
- 39
- Other Operating Expenses Total
- 247.8
- Total Operating Expense
- 548
- Operating Income
- 140.4
- Net Income Before Taxes
- 127.1
- Net Income
- 86.6
- Diluted Normalized EPS
- 2.16
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 633.8
- Selling/ General/ Admin Expenses Total
- 108.54
- Depreciation/ Amortization
- 46.3
- Other Operating Expenses Total
- 231.97
- Total Operating Expense
- 521.13
- Operating Income
- 112.67
- Net Income Before Taxes
- 99.99
- Net Income
- 65.47
- Diluted Normalized EPS
- 1.64
- Period
- 2024-03-31
- Total Assets
- 3852.02
- Total Liabilities
- 2023.66
- Total Equity
- 1828.36
- Tangible Book Valueper Share Common Eq
- 36.38
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 521.09
- Cashfrom Investing Activities
- -752.56
- Cashfrom Financing Activities
- 216.76
- Net Changein Cash
- -14.72
- Period
- 2023-12-31
- Total Revenue
- 605.84
- Selling/ General/ Admin Expenses Total
- 104.25
- Depreciation/ Amortization
- 35.38
- Other Operating Expenses Total
- 228.9
- Total Operating Expense
- 494.09
- Operating Income
- 111.75
- Net Income Before Taxes
- 102.45
- Net Income
- 71.84
- Diluted Normalized EPS
- 1.8
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 652.48
- Selling/ General/ Admin Expenses Total
- 105.67
- Depreciation/ Amortization
- 32.61
- Other Operating Expenses Total
- 229.13
- Total Operating Expense
- 507.82
- Operating Income
- 144.67
- Net Income Before Taxes
- 138.62
- Net Income
- 92.02
- Diluted Normalized EPS
- 2.3
- Period
- 2023-09-30
- Total Assets
- 3418.94
- Total Liabilities
- 1605.73
- Total Equity
- 1813.22
- Tangible Book Valueper Share Common Eq
- 35.8
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 270.88
- Cashfrom Investing Activities
- -369.59
- Cashfrom Financing Activities
- 74.99
- Net Changein Cash
- -23.72
- Period
- 2023-06-30
- Total Revenue
- 606.03
- Selling/ General/ Admin Expenses Total
- 103.91
- Depreciation/ Amortization
- 32.27
- Other Operating Expenses Total
- 215.06
- Total Operating Expense
- 481.23
- Operating Income
- 124.8
- Net Income Before Taxes
- 118.58
- Net Income
- 80.82
- Diluted Normalized EPS
- 10.1
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 575.93
- Selling/ General/ Admin Expenses Total
- 91.77
- Depreciation/ Amortization
- 35.43
- Other Operating Expenses Total
- 198.85
- Total Operating Expense
- 448.13
- Operating Income
- 127.8
- Net Income Before Taxes
- 127.27
- Net Income
- 93.27
- Diluted Normalized EPS
- 11.66
- Period
- 2023-03-31
- Total Assets
- 2941.3
- Total Liabilities
- 1271.76
- Total Equity
- 1669.54
- Tangible Book Valueper Share Common Eq
- 160.42
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 563.23
- Cashfrom Investing Activities
- -615.6
- Cashfrom Financing Activities
- 88.34
- Net Changein Cash
- 35.98
- Period
- 2022-12-31
- Total Revenue
- 562.16
- Selling/ General/ Admin Expenses Total
- 87.2
- Depreciation/ Amortization
- 33.29
- Other Operating Expenses Total
- 200.28
- Total Operating Expense
- 444.27
- Operating Income
- 117.89
- Net Income Before Taxes
- 112.82
- Net Income
- 75.98
- Diluted Normalized EPS
- 9.49
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Krishna Instit Of Medical Scienc Technical
Moving Average
SMA
- 5 Day647.38
- 10 Day657.5
- 20 Day650.04
- 50 Day600.58
- 100 Day604.65
- 300 Day563.48
Krishna Instit Of Medical Scienc Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Global Health
- 1242.7
- 14.5
- 1.18
- 1430
- 936.05
- 33391.61
- Aster Dm Healthcare
- 549.45
- 1.35
- 0.25
- 552.15
- 312.25
- 27440.57
- Krishna Instit Of Medical Scienc
- 660
- 7.1
- 1.09
- 707.5
- 350.02
- 26484.24
- Dr. Lal Pathlabs
- 2788.7
- -24.85
- -0.88
- 3645
- 2295.1
- 23523.99
- Rainbow Childrens Medicare
- 1359.95
- 7.7
- 0.57
- 1708.5
- 1079.25
- 13788.51
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Global Health
- 65.83
- 10.82
- -
- -
- Aster Dm Healthcare
- 215.43
- 5.78
- 6.24
- 4.26
- Krishna Instit Of Medical Scienc
- 82.02
- 13.9
- 22.79
- 15.53
- Dr. Lal Pathlabs
- 57.32
- 10.65
- 21.87
- 16.8
- Rainbow Childrens Medicare
- 63.03
- 10.83
- 19.88
- 13.8
Krishna Instit Of Medical Scienc Shareholding
Shareholding Pattern
*Promoter pledging: 4.67%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-May-25
- Audited Results
- 06-Feb-25
- Quarterly Results
- 09-Nov-24
- Quarterly Results
- 07-Aug-24
- Quarterly Results
- 28-Jun-24
- Stock Split
- 16-May-24
- Audited Results
- 03-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 18-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 18-Mar-25
- 17-Feb-25
- POM
- 29-Aug-24
- 07-Aug-24
- AGM
- 01-Jan-24
- 30-Nov-23
- POM
- 30-Aug-23
- 18-May-23
- AGM
- 14-Feb-23
- 13-Jan-23
- POM
- 11-Aug-22
- 19-May-22
- AGM
- 13-Jun-22
- 12-May-22
- POM


- Ex-Splits
- Old FV
- New FV
- Description
- 13-Sept-24
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.
